#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bone marrow disorder Adenomatous polyposis coli Hidradenitis Stargardt's disease Complex regional pain syndrome Cryoglobulinaemia Lymphoma Stevens-Johnson syndrome Niemann-Pick disease Partial lipodystrophy Nephropathy Non-renal cell carcinoma of kidney Immunodeficiency common variable Congenital pseudarthrosis Oesophageal adenocarcinoma stage III More trials…

    Learn about Rare Diseases

    Nephroblastoma – Trials in Disease Cytokine release syndrome – Basic Information Factor IX deficiency – Life with Disease Ornithine transcarbamoylase deficiency Haemophagocytic lymphohistiocytosis – Trials in Disease Haemophilia A without inhibitors – Diagnostics Aicardi-Goutieres syndrome – Treatment Chronic granulomatous disease – Life with Disease Haemophilia – Life with Disease Glycogen storage disease type I – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ATUMELNANT Phenazone ARTICAINE HYDROCHLORIDE TALADEGIB Levocarnitine Oxytocin Nalbuphine Hydrochloride Ethanol (96 Per Cent) Lbl-007 Gen1055 Dfv890 AGANIRSEN Nesolicaftor Gentamicin Sulfate Atropine Sulfate Monohydrate Afimetoran Besilate Dihydrate A49 Bemarituzumab Cefuroxime Axetil Ursodoxicoltaurine More therapies…

    Learn about Your Condition

    Sexual dysfunction Endometrial cancer stage I Small intestine carcinoma Viral infection Synovial sarcoma Cardiac arrest Breast cancer recurrent Tricuspid valve disease Eructation Hereditary angioedema Metastatic malignant melanoma Injury Cervix carcinoma stage III Inflammatory bowel disease Antithrombin III deficiency More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on the Effect of Carvedilol for Patients with Cirrhotic Portal Hypertension

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Carvedilol
    France

  • Study Comparing Surgery and Chemoradiotherapy with Capecitabine for Early Rectal Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Capecitabine
    France The Netherlands

  • Study on Liver Fibrosis Assessment Using 68Ga-FAPI-46 Imaging in Patients with Suspected or Confirmed Nonalcoholic Steatohepatitis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Metabolic dysfunction-associated steatohepatitis
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    France

  • Study on Reducing Vedolizumab Dosage for Patients with Inflammatory Bowel Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Vedolizumab
    The Netherlands

  • Study on the Effects of Autologous Bone Marrow-Derived Mononuclear Cells for Patients with Diabetic Foot Syndrome and Lower Limb Ischemia

    Recruiting

    4 1 1
    Investigated Diseases:
    • Diabetic foot
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • AUTOLOGOUS BONE MARROW-DERIVED MONONUCLEAR CELLS
    Czechia

  • Study on Fecal Microbiome Transplantation for Patients with Decompensated Cirrhosis Using Allogeneic Fecal Microbiota Capsules

    Recruiting

    3 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    Spain
Previous Page
1 … 13 14 15 16 17 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!